Selected research
Industry Research
PD-L1 and PIK3CA Testing Product Industry Research Report 2026
Market perspective
The global PD-L1 and PIK3CA Testing Product market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for PD-L1 and PIK3CA Testing Product is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for PD-L1 and PIK3CA Testing Product is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for PD-L1 and PIK3CA Testing Product is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of PD-L1 and PIK3CA Testing Product include Roche, QIAGEN, Foundation Medicine, EntroGen, Amoy Diagnostics, Agilent Technologies and ACCB Biotech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global PD-L1 and PIK3CA Testing Product market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
PD-L1 and PIK3CA Testing Product Market by Company
Roche
QIAGEN
Foundation Medicine
EntroGen
Amoy Diagnostics
Agilent Technologies
ACCB Biotech
PD-L1 and PIK3CA Testing Product Segment by Type
PD-L1
PIK3CA
PD-L1 and PIK3CA Testing Product Segment by Application
Hospital
Diagnostic Center
Others
PD-L1 and PIK3CA Testing Product Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global PD-L1 and PIK3CA Testing Product market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of PD-L1 and PIK3CA Testing Product and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of PD-L1 and PIK3CA Testing Product.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of PD-L1 and PIK3CA Testing Product manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of PD-L1 and PIK3CA Testing Product by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of PD-L1 and PIK3CA Testing Product in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- PD-L1
- PIK3CA
Applications
- Hospital
- Diagnostic Center
- Others
Companies covered
- Roche
- QIAGEN
- Foundation Medicine
- EntroGen
- Amoy Diagnostics
- Agilent Technologies
- ACCB Biotech
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global PD-L1 and PIK3CA Testing Product Market Size (2021-2032)
- 2.2.2 Global PD-L1 and PIK3CA Testing Product Sales (2021-2032)
- 2.2.3 Global PD-L1 and PIK3CA Testing Product Market Average Price (2021-2032)
- 2.3 PD-L1 and PIK3CA Testing Product by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 PD-L1
- 2.3.3 PIK3CA
- 2.4 PD-L1 and PIK3CA Testing Product by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Diagnostic Center
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global PD-L1 and PIK3CA Testing Product Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global PD-L1 and PIK3CA Testing Product Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global PD-L1 and PIK3CA Testing Product Revenue of Manufacturers (2021-2026)
- 3.4 Global PD-L1 and PIK3CA Testing Product Average Price by Manufacturers (2021-2026)
- 3.5 Global PD-L1 and PIK3CA Testing Product Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of PD-L1 and PIK3CA Testing Product, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of PD-L1 and PIK3CA Testing Product, Product Type & Application
- 3.8 Global Manufacturers of PD-L1 and PIK3CA Testing Product, Established Date
- 3.9 Global PD-L1 and PIK3CA Testing Product Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Roche
- 4.1.1 Roche Company Information
- 4.1.2 Roche Business Overview
- 4.1.3 Roche PD-L1 and PIK3CA Testing Product Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Roche PD-L1 and PIK3CA Testing Product Product Portfolio
- 4.1.5 Roche Recent Developments
- 4.2 QIAGEN
- 4.2.1 QIAGEN Company Information
- 4.2.2 QIAGEN Business Overview
- 4.2.3 QIAGEN PD-L1 and PIK3CA Testing Product Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 QIAGEN PD-L1 and PIK3CA Testing Product Product Portfolio
- 4.2.5 QIAGEN Recent Developments
- 4.3 Foundation Medicine
- 4.3.1 Foundation Medicine Company Information
- 4.3.2 Foundation Medicine Business Overview
- 4.3.3 Foundation Medicine PD-L1 and PIK3CA Testing Product Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Foundation Medicine PD-L1 and PIK3CA Testing Product Product Portfolio
- 4.3.5 Foundation Medicine Recent Developments
- 4.4 EntroGen
- 4.4.1 EntroGen Company Information
- 4.4.2 EntroGen Business Overview
- 4.4.3 EntroGen PD-L1 and PIK3CA Testing Product Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 EntroGen PD-L1 and PIK3CA Testing Product Product Portfolio
- 4.4.5 EntroGen Recent Developments
- 4.5 Amoy Diagnostics
- 4.5.1 Amoy Diagnostics Company Information
- 4.5.2 Amoy Diagnostics Business Overview
- 4.5.3 Amoy Diagnostics PD-L1 and PIK3CA Testing Product Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Amoy Diagnostics PD-L1 and PIK3CA Testing Product Product Portfolio
- 4.5.5 Amoy Diagnostics Recent Developments
- 4.6 Agilent Technologies
- 4.6.1 Agilent Technologies Company Information
- 4.6.2 Agilent Technologies Business Overview
- 4.6.3 Agilent Technologies PD-L1 and PIK3CA Testing Product Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Agilent Technologies PD-L1 and PIK3CA Testing Product Product Portfolio
- 4.6.5 Agilent Technologies Recent Developments
- 4.7 ACCB Biotech
- 4.7.1 ACCB Biotech Company Information
- 4.7.2 ACCB Biotech Business Overview
- 4.7.3 ACCB Biotech PD-L1 and PIK3CA Testing Product Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 ACCB Biotech PD-L1 and PIK3CA Testing Product Product Portfolio
- 4.7.5 ACCB Biotech Recent Developments
5 Global PD-L1 and PIK3CA Testing Product Market Scenario by Region
- 5.1 Global PD-L1 and PIK3CA Testing Product Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global PD-L1 and PIK3CA Testing Product Sales by Region: 2021-2032
- 5.2.1 Global PD-L1 and PIK3CA Testing Product Sales by Region: 2021-2026
- 5.2.2 Global PD-L1 and PIK3CA Testing Product Sales by Region: 2027-2032
- 5.3 Global PD-L1 and PIK3CA Testing Product Revenue by Region: 2021-2032
- 5.3.1 Global PD-L1 and PIK3CA Testing Product Revenue by Region: 2021-2026
- 5.3.2 Global PD-L1 and PIK3CA Testing Product Revenue by Region: 2027-2032
- 5.4 North America PD-L1 and PIK3CA Testing Product Market Facts & Figures by Country
- 5.4.1 North America PD-L1 and PIK3CA Testing Product Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America PD-L1 and PIK3CA Testing Product Sales by Country (2021-2032)
- 5.4.3 North America PD-L1 and PIK3CA Testing Product Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe PD-L1 and PIK3CA Testing Product Market Facts & Figures by Country
- 5.5.1 Europe PD-L1 and PIK3CA Testing Product Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe PD-L1 and PIK3CA Testing Product Sales by Country (2021-2032)
- 5.5.3 Europe PD-L1 and PIK3CA Testing Product Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific PD-L1 and PIK3CA Testing Product Market Facts & Figures by Country
- 5.6.1 Asia Pacific PD-L1 and PIK3CA Testing Product Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific PD-L1 and PIK3CA Testing Product Sales by Country (2021-2032)
- 5.6.3 Asia Pacific PD-L1 and PIK3CA Testing Product Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America PD-L1 and PIK3CA Testing Product Market Facts & Figures by Country
- 5.7.1 South America PD-L1 and PIK3CA Testing Product Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America PD-L1 and PIK3CA Testing Product Sales by Country (2021-2032)
- 5.7.3 South America PD-L1 and PIK3CA Testing Product Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa PD-L1 and PIK3CA Testing Product Market Facts & Figures by Country
- 5.8.1 Middle East and Africa PD-L1 and PIK3CA Testing Product Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa PD-L1 and PIK3CA Testing Product Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa PD-L1 and PIK3CA Testing Product Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global PD-L1 and PIK3CA Testing Product Sales by Type (2021-2032)
- 6.1.1 Global PD-L1 and PIK3CA Testing Product Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global PD-L1 and PIK3CA Testing Product Sales Market Share by Type (2021-2032)
- 6.2 Global PD-L1 and PIK3CA Testing Product Revenue by Type (2021-2032)
- 6.2.1 Global PD-L1 and PIK3CA Testing Product Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global PD-L1 and PIK3CA Testing Product Revenue Market Share by Type (2021-2032)
- 6.3 Global PD-L1 and PIK3CA Testing Product Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global PD-L1 and PIK3CA Testing Product Sales by Application (2021-2032)
- 7.1.1 Global PD-L1 and PIK3CA Testing Product Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global PD-L1 and PIK3CA Testing Product Sales Market Share by Application (2021-2032)
- 7.2 Global PD-L1 and PIK3CA Testing Product Revenue by Application (2021-2032)
- 7.2.1 Global PD-L1 and PIK3CA Testing Product Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global PD-L1 and PIK3CA Testing Product Revenue Market Share by Application (2021-2032)
- 7.3 Global PD-L1 and PIK3CA Testing Product Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 PD-L1 and PIK3CA Testing Product Value Chain Analysis
- 8.1.1 PD-L1 and PIK3CA Testing Product Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 PD-L1 and PIK3CA Testing Product Production Mode & Process
- 8.2 PD-L1 and PIK3CA Testing Product Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 PD-L1 and PIK3CA Testing Product Distributors
- 8.2.3 PD-L1 and PIK3CA Testing Product Customers
9 Global PD-L1 and PIK3CA Testing Product Analyzing Market Dynamics
- 9.1 PD-L1 and PIK3CA Testing Product Industry Trends
- 9.2 PD-L1 and PIK3CA Testing Product Industry Drivers
- 9.3 PD-L1 and PIK3CA Testing Product Industry Opportunities and Challenges
- 9.4 PD-L1 and PIK3CA Testing Product Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst